Docusign Inc. (NASDAQ:DOCU – Get Free Report) has earned an average recommendation of “Hold” from the sixteen brokerages that are presently covering the company, MarketBeat Ratings reports. Twelve investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $89.77.
Several equities analysts have weighed in on DOCU shares. JMP Securities reissued a “market outperform” rating and set a $124.00 price target on shares of Docusign in a research report on Tuesday, June 3rd. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a research note on Friday, June 6th. UBS Group decreased their price target on shares of Docusign from $85.00 to $80.00 and set a “neutral” rating on the stock in a research note on Friday, June 6th. Bank of America cut their price objective on shares of Docusign from $88.00 to $85.00 and set a “neutral” rating for the company in a research report on Friday, June 6th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Docusign from $81.00 to $77.00 and set a “neutral” rating on the stock in a research note on Friday, June 6th.
Check Out Our Latest Stock Analysis on DOCU
Insider Transactions at Docusign
Hedge Funds Weigh In On Docusign
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Banque Transatlantique SA acquired a new stake in shares of Docusign in the first quarter valued at about $26,000. Hemington Wealth Management boosted its stake in shares of Docusign by 318.1% in the first quarter. Hemington Wealth Management now owns 347 shares of the company’s stock valued at $28,000 after purchasing an additional 264 shares during the period. Golden State Wealth Management LLC increased its stake in Docusign by 519.4% during the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company’s stock worth $31,000 after buying an additional 322 shares during the period. Summit Securities Group LLC acquired a new position in Docusign in the 1st quarter worth $34,000. Finally, Wood Tarver Financial Group LLC acquired a new stake in shares of Docusign during the fourth quarter valued at about $37,000. Institutional investors and hedge funds own 77.64% of the company’s stock.
Docusign Price Performance
Shares of NASDAQ:DOCU opened at $80.39 on Tuesday. The firm has a market capitalization of $16.24 billion, a price-to-earnings ratio of 15.20, a price-to-earnings-growth ratio of 29.81 and a beta of 1.08. The business’s 50 day simple moving average is $79.96 and its 200-day simple moving average is $82.92. Docusign has a 12 month low of $48.80 and a 12 month high of $107.86.
Docusign (NASDAQ:DOCU – Get Free Report) last announced its earnings results on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.81 by $0.09. The company had revenue of $763.65 million during the quarter, compared to analysts’ expectations of $748.79 million. Docusign had a net margin of 36.50% and a return on equity of 14.27%. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.82 earnings per share. On average, equities analysts anticipate that Docusign will post 1.17 earnings per share for the current year.
Docusign declared that its Board of Directors has authorized a stock repurchase program on Thursday, June 5th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to purchase up to 6.6% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s management believes its stock is undervalued.
About Docusign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
- Five stocks we like better than Docusign
- Stock Sentiment Analysis: How it Works
- Why the American Eagle Stock Rally Isn’t Just Speculation
- With Risk Tolerance, One Size Does Not Fit All
- D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?
- Airline Stocks – Top Airline Stocks to Buy Now
- 4 Stocks Planning to Substantially Boost Buybacks After Solid Q2
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.